ATL-derived exosomes modulate mesenchymal stem cells: potential role in leukemia progression

Area of Science:

• Cell Biology
• Cancer Research
• Exosome Biology

Background:

• Exosomes are nano-vesicles involved in intercellular communication, carrying proteins, lipids, and nucleic acids.
• Mesenchymal stem cells (MSCs) interact with cancer cells and their exosomes, influencing pathological processes.
• Adult T-cell leukemia/lymphoma (ATL) is a malignancy where cell-cell interactions may involve exosome-mediated signaling.

Purpose of the Study:

• To investigate if exosomes derived from ATL cells transfer leukemia-related genes to human MSCs.
• To determine if ATL-derived exosomes modulate MSC properties to favor leukemia establishment.
• To explore the role of ATL-derived exosome cargo in altering MSC behavior.

Main Methods:

• Characterization of exosomes released by ATL cell lines (C81, HuT-102) and patient-derived cells.
• Analysis of exosome cargo, including Tax protein and specific microRNAs (miR-21, miR-155).
• Assessment of the effects of ATL-derived exosomes on recipient MSCs, including NF-κB activation, morphology, proliferation, and gene expression.

Main Results:

• ATL cells and patient-derived cells release Tax-containing exosomes.
• Exosomes from HuT-102 cells contained Tax, miR-21, miR-155, and vascular endothelial growth factor.
• ATL-derived exosomes delivered Tax to MSCs, activating NF-κB, altering morphology, increasing proliferation, and inducing migration and angiogenic markers.

Conclusions:

• ATL-derived exosomes act as intercellular messengers, transferring leukemia-associated genes to MSCs.
• These exosomes modify MSC properties, potentially creating a microenvironment conducive to leukemia.
• Leukemia-derived exosomes represent promising biomarkers and therapeutic targets for ATL.